NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

LQDA

Liquidia Corp

Jul 11 • 04:00PM ET

14.09

Dollar change -0.06
Percentage change -0.42	%

Healthcare • Biotechnology • USA • NASD

Peers: REGN VRTX ALNY SRPT NBIX ARWR IONS RGEN MDGL XNCR

| Held by: VTI IWM VXF IWO VTWO KOMP SCHA VHT XPH IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.56	Insider Own	19.51%	Shs Outstand	85.30M	Perf Week	15.59%
Market Cap	1.20B	Forward P/E	-	EPS next Y	-0.11	Insider Trans	-1.20%	Shs Float	68.81M	Perf Month	-5.94%
Enterprise Value	1.14B	PEG	-	EPS next Q	-0.42	Inst Own	60.89%	Short Float	31.03%	Perf Quarter	10.34%
Income	-127.83M	P/S	85.18	EPS this Y	7.31%	Inst Trans	8.32%	Short Ratio	10.10	Perf Half Y	13.63%
Sales	14.14M	P/B	24.18	EPS next Y	93.17%	ROA	-60.22%	Short Interest	21.35M	Perf YTD	19.81%
Book/sh	0.58	P/C	7.10	EPS next 5Y	-	ROE	-188.03%	52W High	19.41 -27.41%	Perf Year	11.56%
Cash/sh	1.99	P/FCF	-	EPS past 3/5Y	-33.51% 8.44%	ROIC	-80.21%	52W Low	8.26 70.58%	Perf 3Y	235.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.36% 11.64%	Gross Margin	49.18%	Volatility	5.10% 5.52%	Perf 5Y	78.81%
Dividend TTM	-	EV/Sales	80.96	EPS Y/Y TTM	0.26%	Oper. Margin	-904.40%	ATR (14)	0.85	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.91	Sales Y/Y TTM	-11.42%	Profit Margin	-903.80%	RSI (14)	52.19	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.93	EPS Q/Q	17.02%	SMA20	6.23%	Beta	0.11	Target Price	30.30
Payout	-	Debt/Eq	2.21	Sales Q/Q	4.98%	SMA50	-6.19%	Rel Volume	0.68	Prev Close	14.15
Employees	157	LT Debt/Eq	2.21	Earnings	May 08 BMO	SMA200	6.09%	Avg Volume	2.12M	Price	14.09
IPO	Jul 26, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.14% -4.49%	Trades		Volume	1,447,049	Change	-0.42%

Date	Action	Analyst	Rating Change	Price Target Change
May-19-25	Downgrade	Oppenheimer	Perform → Underperform	$13
Dec-20-24	Initiated	Wells Fargo	Overweight	$20
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform	$27
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy	$18 → $28
Sep-19-22	Resumed	Wedbush	Underperform	$3
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform	$3
Jul-22-22	Initiated	Ladenburg Thalmann	Buy	$15
May-31-22	Initiated	BTIG Research	Buy	$14
May-26-22	Initiated	BofA Securities	Buy	$12
Dec-04-20	Initiated	H.C. Wainwright	Buy	$6
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral	$20 → $4
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform	$26
Aug-20-18	Initiated	Needham	Buy	$30
Aug-20-18	Initiated	Jefferies	Buy	$22

Show Previous Ratings

Jun-23-25 04:34PM	Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA (GlobeNewswire)
Jun-11-25 11:04AM	Insmed Stock Jumps 29% on Encouraging PAH Study Results (Zacks) -5.67%
Jun-10-25 04:07PM	Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia (Investor's Business Daily) -16.87%
Jun-02-25 06:30AM	Liquidia Schedules First Commercial Shipment of YUTREPIA (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD (GlobeNewswire) +13.07%
May-28-25 08:00AM	Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference (GlobeNewswire) -9.13%
10:47AM	Loading…
May-24-25 10:47AM	FDA Approves Liquidia Corporation (LQDA)'s YUTREPIA Amid Patent Dispute (Insider Monkey)
May-23-25 02:28PM	U.S. FDA Approves Liquidia's YUTREPIA (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) (GlobeNewswire)
May-12-25 06:00AM	Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics (GlobeNewswire)
May-09-25 03:21AM	Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... (GuruFocus.com)
May-08-25 11:06AM	Buckley Capital's Views on Liquidia Corp. (LQDA) (Insider Monkey)
07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
May-07-25 06:35PM	Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
11:16AM	Liquidia Q1 2025 Earnings Preview (Seeking Alpha)
10:15AM	Loading…
10:15AM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result (GuruFocus.com)
May-06-25 08:00AM	Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference (GlobeNewswire)
May-05-25 04:06PM	Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month (Seeking Alpha)
09:50AM	Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains? (Zacks)
May-02-25 05:28PM	District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia (GlobeNewswire) +13.23%
May-01-25 08:00AM	Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-30-25 09:30AM	Arquitos Capital's Largest Holdings For Q1 2025 (Seeking Alpha)
Apr-29-25 07:40AM	Regeneron (REGN) Lags Q1 Earnings and Revenue Estimates (Zacks) -5.06%
05:16AM	Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last? (Zacks)
Apr-25-25 06:30AM	Arquitos Capital Management Q1 2025 Investor Letter (Seeking Alpha)
Apr-07-25 06:38AM	Liquidia: United Therapeutics Has The Last Laugh (Seeking Alpha)
Apr-01-25 10:33AM	UPDATE Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
08:00AM	Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-28-25 09:30AM	Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA (treprostinil) Inhalation Powder (GlobeNewswire)
Mar-27-25 08:00AM	Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference (GlobeNewswire)
06:23PM	Loading…
Mar-21-25 06:23PM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result (GuruFocus.com)
Mar-20-25 01:01AM	Q4 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-19-25 11:56AM	Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript (SeekingAlpha)
07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-18-25 08:00AM	Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million (GlobeNewswire)
Mar-12-25 08:00AM	Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 (GlobeNewswire)
Feb-24-25 07:00AM	Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors (GlobeNewswire)
Jan-22-25 09:12AM	Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Jan-08-25 08:00AM	Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-27-24 07:11PM	Jim Cramer's Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know (Insider Monkey)
Dec-12-24 10:00AM	Heres Arquitos Capital Managements Updates on Liquidia (LQDA) (Insider Monkey)
09:55AM	Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect? (Zacks)
Nov-26-24 09:55AM	Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High? (Zacks)
Nov-14-24 02:09AM	Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ... (GuruFocus.com)
Nov-13-24 07:40AM	Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-12-24 08:00AM	Liquidia to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-08-24 07:04AM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result (GuruFocus.com)
Nov-06-24 08:00AM	Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024 (GlobeNewswire)
Nov-04-24 08:00AM	Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024 (GlobeNewswire)
Oct-29-24 10:01AM	Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-09-24 05:12PM	Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... (GuruFocus.com)
Oct-08-24 09:34AM	Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains? (Zacks)
Oct-07-24 10:00AM	United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent (GlobeNewswire) +11.17%
Oct-02-24 06:00AM	Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606) (GlobeNewswire)
Sep-30-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm (GlobeNewswire)
08:00AM	Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting (GlobeNewswire)
Sep-16-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm (GlobeNewswire)
09:41AM	Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million (GlobeNewswire)
Sep-12-24 07:02PM	Caligan Partners LP Bolsters Portfolio with Significant Stake in Liquidia Corp (GuruFocus.com)
07:00AM	Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock? (Zacks)
Sep-11-24 08:26AM	Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement (GlobeNewswire) +14.10%
Aug-28-24 08:00AM	Liquidia to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-26-24 02:19PM	Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going Down, Down, Down (Insider Monkey)
Aug-22-24 06:00AM	Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD (GlobeNewswire)
Aug-20-24 10:27AM	Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia (Zacks)
06:33AM	Liquidias YUTREPIA inhalation powder gains tentative FDA approval (Pharmaceutical Technology)
Aug-19-24 04:01PM	Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 31% (Investor's Business Daily) -30.62%
11:11AM	Midday movers: B. Riley, HP Inc fall; AMD rises (Investing.com)
06:00AM	U.S. FDA Grants Tentative Approval of YUTREPIA (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) (GlobeNewswire)
Aug-16-24 06:30AM	Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions (GlobeNewswire)
Aug-09-24 07:45AM	Why Is Liquidia Corporation (LQDA) The Best Among Caligan Partners Top Holdings? (Insider Monkey)
Aug-07-24 07:40AM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire)
Jun-18-24 08:42AM	Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH) (GlobeNewswire) -6.08%
Jun-03-24 04:33PM	Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics (Investor's Business Daily) +12.67%
07:00AM	District Court Issues Favorable Ruling and Denies United Therapeutics' Request to Block YUTREPIA Launch (GlobeNewswire)
May-29-24 08:00AM	Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 03:03AM	Liquidia Corp (LQDA) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ... (GuruFocus.com)
02:05AM	Q1 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
May-14-24 09:35AM	Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA) (Zacks)
08:53AM	LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-13-24 05:43PM	Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-10-24 08:00AM	Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD (GlobeNewswire)
May-07-24 08:30AM	Liquidia Corporation to Present at BofA Securities Health Care Conference 2024 (GlobeNewswire)
08:00AM	Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Apr-25-24 10:02AM	Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline (Zacks)
Apr-02-24 09:00AM	Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 06:00AM	Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Mar-20-24 01:50AM	Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA) (GuruFocus.com)
01:49AM	Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) (GuruFocus.com)
Mar-16-24 02:42PM	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 10:54PM	Q4 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) +5.36%
07:31AM	Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results (GuruFocus.com)
07:10AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-06-24 06:30AM	Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-21-24 03:17PM	United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings (Benzinga)

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schundler Russell	General Counsel	Jun 04 '25	Sale	16.97	8,460	143,566	582,054	Jun 05 04:20 PM
Moomaw Scott	Chief Commercial Officer	Jun 04 '25	Sale	16.97	6,656	112,952	224,921	Jun 05 04:20 PM
Saggar Rajeev	Chief Medical Officer	Jun 04 '25	Sale	16.97	7,597	128,921	273,209	Jun 05 04:19 PM
JEFFS ROGER	Chief Executive Officer	Jun 04 '25	Sale	16.97	30,610	519,452	1,044,979	Jun 05 04:18 PM
Kaseta Michael	CFO and COO	Jun 04 '25	Sale	16.97	14,777	250,766	412,164	Jun 05 04:18 PM
Adair Jason	Chief Business Officer	Jun 04 '25	Sale	16.97	3,597	61,041	193,735	Jun 05 04:15 PM
Schundler Russell	General Counsel	Jun 02 '25	Sale	16.74	923	15,451	571,722	Jun 03 04:49 PM
Moomaw Scott	Chief Commercial Officer	Jun 02 '25	Sale	16.74	581	9,726	216,038	Jun 03 04:47 PM
Kaseta Michael	CFO and COO	Jun 02 '25	Sale	16.74	859	14,380	397,800	Jun 03 04:45 PM
Adair Jason	Chief Business Officer	Jun 02 '25	Sale	16.74	451	7,550	184,961	Jun 03 04:44 PM
Adair Jason	Chief Business Officer	Apr 28 '25	Sale	14.24	455	6,479	183,849	Apr 30 04:15 PM
Saggar Rajeev	Chief Medical Officer	Apr 21 '25	Sale	13.67	2,450	33,492	263,152	Apr 23 04:15 PM
Schundler Russell	General Counsel	Apr 14 '25	Sale	13.57	5,964	80,931	570,301	Apr 16 05:06 PM
JEFFS ROGER	Chief Executive Officer	Apr 14 '25	Sale	13.57	14,130	191,744	1,006,420	Apr 16 05:05 PM
Moomaw Scott	Chief Commercial Officer	Apr 15 '25	Sale	13.57	3,406	46,219	214,744	Apr 16 05:04 PM
Kaseta Michael	CFO and COO	Apr 14 '25	Sale	13.57	8,283	112,400	396,315	Apr 16 05:03 PM
Saggar Rajeev	Chief Medical Officer	Apr 14 '25	Sale	13.57	3,714	50,399	265,602	Apr 16 05:02 PM
Adair Jason	Chief Business Officer	Apr 14 '25	Sale	13.57	1,856	25,186	184,304	Apr 15 09:12 PM
Schundler Russell	General Counsel	Mar 03 '25	Sale	15.45	930	14,368	576,265	Mar 04 04:32 PM
Moomaw Scott	Chief Commercial Officer	Mar 03 '25	Sale	15.45	592	9,146	218,150	Mar 04 04:31 PM
Kaseta Michael	CFO and COO	Mar 03 '25	Sale	15.45	874	13,503	404,598	Mar 04 04:31 PM
Adair Jason	Chief Business Officer	Mar 03 '25	Sale	15.45	451	6,968	182,254	Mar 04 04:30 PM
Adair Jason	Chief Business Officer	Jan 27 '25	Sale	14.20	445	6,319	179,770	Jan 29 04:40 PM
Saggar Rajeev	Chief Medical Officer	Jan 21 '25	Sale	13.00	2,445	31,785	267,943	Jan 23 05:00 PM
Schundler Russell	General Counsel	Jan 14 '25	Sale	11.78	16,393	193,110	573,478	Jan 14 04:39 PM
Saggar Rajeev	Chief Medical Officer	Jan 14 '25	Sale	11.78	6,249	73,613	270,388	Jan 14 04:39 PM
Moomaw Scott	Chief Commercial Officer	Jan 14 '25	Sale	11.78	8,362	98,504	215,494	Jan 14 04:38 PM
Kaseta Michael	CFO and COO	Jan 14 '25	Sale	11.78	23,370	275,299	401,755	Jan 14 04:37 PM
Adair Jason	Chief Business Officer	Jan 14 '25	Sale	11.78	4,809	56,650	180,215	Jan 14 04:36 PM
JEFFS ROGER	Chief Executive Officer	Jan 14 '25	Sale	11.78	22,343	263,201	1,019,177	Jan 14 04:35 PM
Moomaw Scott	Chief Commercial Officer	Dec 02 '24	Sale	11.51	546	6,284	154,127	Dec 03 09:45 PM
Kaseta Michael	CFO and COO	Dec 02 '24	Sale	11.51	1,091	12,557	312,328	Dec 03 09:44 PM
Schundler Russell	General Counsel	Dec 02 '24	Sale	11.51	1,063	12,235	487,328	Dec 03 09:43 PM
Adair Jason	Chief Business Officer	Dec 02 '24	Sale	11.51	455	5,237	119,223	Dec 03 09:43 PM
Saggar Rajeev	Chief Medical Officer	Oct 18 '24	Sale	11.19	2,526	28,266	204,857	Oct 22 04:15 PM
Schundler Russell	General Counsel	Oct 14 '24	Sale	11.11	2,576	28,613	486,048	Oct 15 08:12 PM
Saggar Rajeev	Chief Medical Officer	Oct 14 '24	Sale	11.11	2,260	25,103	207,383	Oct 15 08:11 PM
Moomaw Scott	Chief Commercial Officer	Oct 14 '24	Sale	11.11	1,527	16,961	152,798	Oct 15 08:10 PM
Kaseta Michael	CFO and COO	Oct 14 '24	Sale	11.11	3,892	43,231	311,076	Oct 15 08:08 PM
JEFFS ROGER	Chief Executive Officer	Oct 14 '24	Sale	11.11	8,053	89,450	812,193	Oct 15 08:06 PM
Adair Jason	Chief Business Officer	Oct 14 '24	Sale	11.11	1,146	12,729	118,574	Oct 15 08:06 PM
Manning Paul B	Director	Sep 12 '24	Buy	8.90	337,078	2,999,994	816,311	Sep 16 04:05 PM
Caligan Partners LP	Director	Aug 30 '24	Buy	9.51	150,000	1,426,500	6,994,997	Sep 04 05:51 PM
Caligan Partners LP	Director	Aug 30 '24	Sale	9.51	150,000	1,426,500	6,844,997	Sep 04 05:51 PM
Adair Jason	Chief Business Officer	Sep 03 '24	Sale	9.50	455	4,322	115,814	Sep 04 04:51 PM
Schundler Russell	General Counsel	Sep 03 '24	Sale	9.50	710	6,745	488,624	Sep 04 04:44 PM
Moomaw Scott	Chief Commercial Officer	Sep 03 '24	Sale	9.50	546	5,187	154,325	Sep 04 04:44 PM
Kaseta Michael	CFO and COO	Sep 03 '24	Sale	9.50	1,079	10,250	314,968	Sep 04 04:40 PM
Adair Jason	Chief Business Officer	Jul 26 '24	Sale	11.44	1,833	20,970	113,393	Jul 29 04:30 PM
Saggar Rajeev	Chief Medical Officer	Jul 19 '24	Sale	11.13	1,873	20,846	208,329	Jul 22 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LQDA

Liquidia Corp

Upgrade your FINVIZ experience